The Scientific World Journal, 2014 Introduction. This study prospectively evaluates and compares the treatment efficacy of botulinum toxin injection under electromyography guidance (EMG group) and percutaneous botulinum toxin injection under flexible fiberscopic guidance (fiberscopy group)
Jae Wook Kim +3 more
doaj +1 more source
Clinical significance of the buccal fat pad: how to determine the correct surgical indications based on preoperative analysis [PDF]
, 2018 Background: Despite the multitude of clinical and aesthetic uses, the correct surgical indications for buccal fat pad (BFP) removal have yet to be fully elucidated.
Bencardino, Davide +6 more
core +1 more source
Journal of Orthopaedic Research, EarlyView.Wistar rats underwent supraspinatus tendon tear and reconstruction. Then, rats were divided into Cage activity, Immobilization, Immobilization + Early exercise, and Immobilization + Delayed exercise groups. After 3 and 6 weeks of surgery, histological and biomechanical analyses were performed.
Haruna Misuo +7 more
wiley +1 more source
Botulinum Toxin in the Treatment of Lingual Dystonia Induced by Speaking
Case Reports in Neurology, 2013 Primary lingual dystonia is a rare condition, especially when it is only induced by speaking. Trihexyphenidyl failed to improve the symptoms. Several case series have demonstrated the effectiveness of botulinum toxin injection for the management of focal
F. Budak +3 more
doaj +1 more source
Amylase release from streptolysin O-permeabilized pancreatic acinar cells. Effects of Ca2+, guanosine 5'-[gamma-thio]triphosphate, cyclic AMP, tetanus toxin and botulinum A toxin [PDF]
, 1992 The molecular requirements for amylase release and the intracellular effects of botulinum A toxin and tetanus toxin on amylase release were investigated using rat pancreatic acinar cells permeabilized with streptolysin O.
Ahnert-Hilger, G. +4 more
core
Guideline on the use of onabotulinumtoxinA in chronic migraine. a consensus statement from the European Headache Federation [PDF]
, 2018 OnabotulinumtoxinA is being increasingly used in the management of chronic migraine (CM). Treatment with onabotulinumtoxinA poses challenges compared with traditional therapy with orally administered preventatives.
Ahmed, Fayyaz +8 more
core +3 more sources
JPGN Reports, EarlyView.Abstract Objectives Patients with cerebral palsy (CP) often have gastrointestinal dysmotility. An inciting event, such as infection, may lead to progressive decline in bowel motility and episodes of acute pediatric intestinal pseudo‐obstruction (PIPO).
Zoe Saenz +4 more
wiley +1 more source
Australasian Journal of Plastic Surgery**Background**: Synkinesis may develop following facial nerve palsy, impacting quality of life. Botulinum toxin treatment for synkinesis is commonly used, but buccinator muscle injection is less common.
Raymond Hayler +4 more
doaj +1 more source
Vasculitis with panniculitis following botulinum toxin A injection for cosmetic use
Dermatology Practical & Conceptual, 2016 Botulinum toxin A injection is performed most frequently for facial rejuvenation all over the world. Some bizarre and severe side effects have been reported after botulinum toxin A injection.
Nastaran Namazi +4 more
doaj +1 more source
Challenging the Clostridium botulinum toxin type A (BoNT/A) with a selection of microorganisms by culture methods and extended storage of used vials to assess the loss of sterility [PDF]
, 2015 In 2002, botulinum toxin type A (BoNT/A) was approved by the US Food and Drug Administration (FDA) for cosmetic use. However, there may be procedural differences between the ways in which a clinician handles, applies and stores the product compared to ...
Crean, Stjohn +4 more
core